MIS416 as a siRNA Delivery System with the Ability to Target Antigen-Presenting Cells.
Saved in:
| Title: | MIS416 as a siRNA Delivery System with the Ability to Target Antigen-Presenting Cells. |
|---|---|
| Authors: | Mainini F; 1 Department of Pathology, University of Otago , Dunedin, New Zealand ., Larsen DS; 2 Department of Chemistry, University of Otago , Dunedin, New Zealand ., Webster GA; 3 Innate Immunotherapeutics Ltd. , Penrose, New Zealand ., Young SL; 1 Department of Pathology, University of Otago , Dunedin, New Zealand .; 4 Maurice Wilkins Center for Molecular Biodiscovery , Auckland, New Zealand ., Eccles MR; 1 Department of Pathology, University of Otago , Dunedin, New Zealand .; 4 Maurice Wilkins Center for Molecular Biodiscovery , Auckland, New Zealand . |
| Source: | Nucleic acid therapeutics [Nucleic Acid Ther] 2018 Aug; Vol. 28 (4), pp. 225-232. Date of Electronic Publication: 2018 Jun 12. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 101562758 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2159-3345 (Electronic) Linking ISSN: 21593337 NLM ISO Abbreviation: Nucleic Acid Ther Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 2159-3345 |
|---|---|
| DOI: | 10.1089/nat.2017.0695 |
